Impact of cytokine gene polymorphism on cardiovascular risk in renal transplant recipients

被引:12
作者
Altun, B
Yilmaz, R
Kahraman, S
Gençtoy, G
Arici, M
Önalan, O
Oto, A
Hayran, M
Bakkaloglu, M
Yasavul, Ü
Turgan, Ç
机构
[1] Hacettepe Univ, Fac Med, Dept Internal Med, Div Nephrol, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey
[3] Hacettepe Univ, Fac Med, Dept Radiol, TR-06100 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Canc Epidemiol, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Dept Urol, TR-06100 Ankara, Turkey
关键词
cardiovascular disease; cytokine; transplantation;
D O I
10.1111/j.1432-2277.2005.00118.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cardiovascular events are the leading causes of morbidity and mortality in renal transplant recipients (RTR). Given the role of inflammation in atherosclerosis, the contribution of functional polymorphisms of cytokines to cardiovascular diseases (CVD) was assessed in RTR in this study. Polymorphisms of tumour necrosis factor alpha (TNF-alpha) gene [-308 (G -> A), -238 (G -> A)], interleukin-10 (IL-10) gene [-1082(A -> G), -819 (T -> C)], -592 (A -> C), transforming growth factor beta 1 (TGF-beta 1) gene [codon 10 (T -> C), codon 25 (G -> C)], carotis intima media thickness (CIMT), left ventricular mass index (LVMI), 24-h ambulatory blood pressure and serum lipoprotein homocysteine level, erythrocyte sedimentation rate, serum C-reactive protein (CRP) and serum fibrinogen level of RTR were determined. Seventy-two RTR (26 cadaveric allograft, 46 living-related allograft, 43 male, 29 female) were included in this study. LVMI were similar in TNF-alpha, IL-10 and TGF-beta 1 genotypes. Right and left CIMT were higher in TT genotype (n = 16) than CT (n = 46) and CC (n = 10) genotypes of TGF-beta 1 codon 10 (T -> C) gene polymorphism (RCIMT, 7.7 +/- 2.2 mm vs. 7.0 +/- 1.4 mm vs. 5.9 +/- 1.4 mm, P = 0.025; LCIMT, 8.5 +/- 2.5 mm vs. 7.0 +/- 1.3 mm vs. 6.1 +/- 1.2 mm, P = 0.002). Lipoprotein (a) level of TT genotype (35.5 +/- 22.5 mg/dl) was higher than CC (4.1 +/- 2.8 mg/dl) and CT (20.4 +/- 11.2 mg/dl) genotypes of TGF-beta 1 codon 10 (T -> C) gene polymorphism (P = 0.037). High producers of cytokine IL-10 -1082 [GG (n = 22) vs. AA + AG (n = 50)] and low producers of TGF-beta codon 25 [GC + CC (n = 17) vs. GG (n = 55)] had lower IMT of carotid artery but the difference did not reach statistical significance (P > 0.05). The CIMT of renal transplant patients was similar in IL-10 (-819, -592) and TNF-alpha (-308, -238) genotypes. No difference was observed in 24-h ambulatory blood pressure levels, serum lipoproteins, plasma homocysteine level, erythrocyte sedimentation rate, serum CRP, serum fibrinogen level in IL-10, TNF-alpha and TGF-beta 1 genotypes. Besides the well-known factors, TGF-beta 1 gene polymorphisms might play a role in CVD in RTR even at early stages of asymptomatic atherosclerosis.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
  • [21] Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events
    Mansell, Holly
    Soliman, Mahmoud
    Elmoselhi, Hamdi
    Shoker, Ahmed
    PLOS ONE, 2015, 10 (11):
  • [22] Urinary Proinflammatory Cytokine Response in Renal Transplant Recipients With Polyomavirus BK Viruria
    Sadeghi, Mahmoud
    Daniel, Volker
    Schnitzler, Paul
    Lahdou, Imad
    Naujokat, Cord
    Zeier, Martin
    Opelz, Gerhard
    TRANSPLANTATION, 2009, 88 (09) : 1109 - 1116
  • [23] Transplant clinical pharmacy services improve cardiovascular risk factor management and control in Veteran organ transplant recipients
    Elmaasarani, Zana
    Schumann, Eric
    Taber, David J.
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (03): : 280 - 287
  • [24] Subclinical atherosclerosis and related risk factors in renal transplant recipients
    Mitra Basiratnia
    Mojtaba Fazel
    Mehrzad Lotfi
    Ghamar Hosseini Al-Hashemi
    Mohammad Hossein Fallahzadeh
    Ali Derakhshan
    Mahdi Salehipour
    Pediatric Nephrology, 2010, 25 : 343 - 348
  • [25] Risk factors for chronic renal dysfunction in lung transplant recipients
    Esposito, Ciro
    De Mauri, Andreana
    Vitulo, Patrizio
    Oggionni, Tiberio
    Cornacchia, Flavia
    Valentino, Rossella
    Grosjean, Fabrizio
    Torreggiani, Massimo
    Dal Canton, Antonio
    TRANSPLANTATION, 2007, 84 (12) : 1701 - 1703
  • [26] Risk factors for chronic transplant dysfunction and cardiovascular disease are related to accumulation of advanced glycation end-products in renal transplant recipients
    Hartog, Jasper W. L.
    de Vries, Aiko P. J.
    Bakker, Stephan J. L.
    Graaff, Reindert
    van Son, Willem J.
    van der Heide, Jaap J. Homan
    Gans, Reinold O. B.
    Wolffenbuttel, Bruce H. R.
    de Jong, Paul E.
    Smit, Andries J.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (08) : 2263 - 2269
  • [27] Cardiovascular morbidity and risk factors in renal transplant patients
    Aakhus, S
    Dahl, K
    Wideroe, TE
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (03) : 648 - 654
  • [28] The impact of early cytomegalovirus infection and disease in renal transplant recipients
    Sagedal, S
    Hartmann, A
    Rollag, H
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (07) : 518 - 530
  • [29] Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients
    Irish, AB
    Green, FR
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1997, 12 (01) : 167 - 173
  • [30] Cancers in renal transplant recipients
    Penn, I
    ADVANCES IN RENAL REPLACEMENT THERAPY, 2000, 7 (02): : 147 - 156